MedTrace Logo

Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy

NCT02140502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-05-17

No results posted yet for this study

Summary

In this study, the investigators aim to establish the incidence of enteric fluoroquinolone resistant bacteria in a contemporary clinical cohort. This incidence will be studied by taking a rectal swab sample from all consenting patients coming in for prostate biopsies. The information gained from this study will be used to determine whether antibiotic prophylactic practices need to be updated in their clinic. The investigators aim to enroll 200 patients and patient recruitment is estimated to take place between May 2014 and August 2014. The study is estimated to end in May 2016.

Conditions

  • Fluoroquinolone Resistant Enteric Bacteria

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER

  • HUSLAB

    collaborator UNKNOWN

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Antti Rannikko, MD, PhD · Helsinki University Central Hospital

  • Henrikki Santti, M.D., PhD · Helsinki University Central Hospital

  • Kanerva Lahdensuo, M.D. · Helsinki University Central Hospital

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-08-31
Completion
2016-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02140502 on ClinicalTrials.gov